Anvisa Approves New Medicine for Advanced Breast Cancer - 22/09/2026 - Equilibrio E Saúde

UOL

Folha de S.Paulo

View article

Reposted by

Folha de S.Paulo

Lean Left

Factuality

Ownership

Registration was granted to AstraZeneca of Brazil and price will still be evaluated by CMED

bemparana.com.br

Factuality

Ownership

Anvisa (National Health Surveillance Agency) approved the registration of the oral medicine Etcamah (camizestranto) for the treatment of a... The post Anvisa approves new oral medicine against cancer apareceu primeiro em Bem Paraná.

Metrópoles

Factuality

Ownership

Medicinal product is indicated for patients with genetic mutation and may be used prior to visible progression of the disease

CNN Brasil

Factuality

Ownership

Etcamah works in tumor cells, blocking the action and promoting their degradation; medicine is intended for patients without radiological or clinical progression